Taxol 30 mg/5 ml

Taxol 30 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 52364. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 December 1993 and the authorisation is valid without a time limit. ATC code L01CD01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 52364
  • ATC L01CD01
  • Synthetic medicines
Authorisation data
Authorisation number52364
NameTaxol 30 mg/5 ml
Full nameTaxol 30 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderCheplapharm Schweiz GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01CD01
First authorisation20 December 1993
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Taxol 30 mg/5 ml, Konzentrat zur Herstellung einer InfusionslösungA20 December 1993
2Taxol 100 mg/16.7 ml, Konzentrat zur Herstellung einer InfusionslösungA11 June 1996
3Taxol 300 mg/50 ml, Konzentrat zur Herstellung einer InfusionslösungA11 October 1999

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
351Durchstechflasche(n)L01CD0107.16.1.A
431Durchstechflasche(n)L01CD0107.16.1.A
511Durchstechflasche(n)L01CD0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Taxol 30 mg/5 ml authorised in Switzerland?

Yes. Taxol 30 mg/5 ml is authorised by Swissmedic under authorisation number 52364, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Taxol 30 mg/5 ml have?

Taxol 30 mg/5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Taxol 30 mg/5 ml?

The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com